# Kenji Kabashima

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kenji-kabashima/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,833 |
| Field | Dermatology and Skin Diseases |
| h-index | 96 |
| i10-index | 432 |
| Last Known Institution | Agency for Science, Technology and Research |
| OpenAlex ID | https://openalex.org/A5023533946 |
| ORCID iD | https://orcid.org/0000-0002-0773-0554 |
| Works | 1,198 |

## Researcher papers

- [Atopic dermatitis](https://scholariq.org/papers/atopic-dermatitis-2/)
- [Prostaglandin D <sub>2</sub> as a Mediator of Allergic Asthma](https://scholariq.org/papers/prostaglandin-d-sub-2-sub-as-a-mediator-of-allergic-asthma/)
- [Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis](https://scholariq.org/papers/anti-interleukin-31-receptor-a-antibody-for-atopic-dermatitis/)
- [Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/safety-and-efficacy-of-upadacitinib-in-combination-with-topical-corticosteroids/)
- [Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials](https://scholariq.org/papers/baricitinib-in-patients-with-moderate-to-severe-atopic-dermatitis-and-inadequate/)
- [Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder](https://scholariq.org/papers/increasing-comorbidities-suggest-that-atopic-dermatitis-is-a-systemic-disorder/)
- [Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An <scp>EAACI</scp> position paper](https://scholariq.org/papers/nomenclature-of-allergic-diseases-and-hypersensitivity-reactions-adapted-to/)
- [Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis](https://scholariq.org/papers/type-2-inflammation-contributes-to-skin-barrier-dysfunction-in-atopic-dermatitis/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions-2/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)

## Researcher university

- [Agency for Science, Technology and Research](https://scholariq.org/institutions/agency-for-science-technology-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.